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PROGRESS IN BUX)D LIPID REPORTING PRACI-IC’ES IN 
NORTH AMERICA: CHANGES PROM 1985 TO 1990 
Joshua A Engel, Erik K Petersen, Bruce M McManus. University 
of Nebraska Medical Center, Omaha, Nebraska. 
~a an attempt to assess the impact of the National Cholesterol 
Education Panel’s (NCBP) recommendations and in follow-up to 
a 1985 survey of 157 academic linical laboratories (L) in North 
America, the same L were re-surveyed regarding current blood 
lipid reporting practices. There was a marked downward shift in 
normative ranges for total serum cholesterol (TC) used by L. In 
1985 100% of the surveyed laboratories reported a value of >201 
mg/dl as normal or desirable, and 76% reported similar accept- 
ability of values .240 mg/dl, while in 1990 only 29% and ll%, 
respectively, reported such values as desirable. Of the L respond- 
ing to both suweys, 90% lowered their reported normative values, 
with 48% and 8% lowering their ranges by >50 mg/dl and > 100 
mg/dl, respectively. Changes in the sources of normative ranges 
were also noted. In 1985, SO% of ranges were from published 
sources, 9% from manufacturers, and 42% from local popula- 
tions. In 1990,24% of ranges came from published sources 3% 
from manufacturers, 13% from local populations, and 57% from 
the NCEP. The percent of L using reference ranges based on 
age and sex fell from 52% to 21% and from 31% to lo%, respec- 
tively. The number of L designating patient risk for coronary 
heart disease rose from 31% to 72%. Currently, 62% of the L 
designating risk use the NCEP guidelines for TC. Other risk 
designations, including high density lipoprotein (HDL)-C, 
TC/HDLC ratio, and apolipoproteins changed only modestly. 
The current reporting patterns reflect simplified reporting practic- 
es for blood lipids. Although definite progress has been made, 
clinical laboratories remain a substantial distance from the NCEP 
goal of uniformly standardized blood lipid reporting practices. 
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LD(a) DIsrRIBuTI D ITS 
TO PARENTAL OtitiDiAl 
THE 8DGALUSA HEART STUDY 
Sathanur Srinivasan, Gosta Cahlen, Rafael Jarpa, Larry 
Webber, Gerald Berenson, Louisiana State University 
Stefan Jost, Wolf Rafflenbeul, Jaap Deckers, Hartmut 
Medical Center, New Orleans, LA USA 
Hecker, Peter Nikutta, Birgitt Wiese, Paul Lichtlen, and 
the INTACT-investigators. Hannover Medical School, FRG 
The value of Lp(a) in the prediction of CAD risk very 
early in life remains to be established in different 
racial groups. Therefore, serum Lp(a) distribution and 
its relation to parental histories of myocardial 
infarction (MI) were exapined in 2,438 children (8 to 17 
years of age) from a tot;\ biracial community. Parental 
myocardfal infarction was used as a surrogate measure of 
future risk of disease in the offspring. Lp(a) levels 
averaged 1.7-fold higher in blacks than in whites 
(p<0.0001). A small but significant gender difference 
(females > males, p < 0.05) was seen in both races. 
Race, sexual maturation, and gender accounted for 9.4% 
of the variability of Lp(a) in serum. White children 
with parental MI (n=gO) had increased levels of Lp( a) 
compared with those without parental MI (22.4 mg/dl vs 
17.1 mg/dl, p<O.Ol). Further, among white children, the 
prevalence of parental MI was higher in those with Lp(a) 
levels above 25 mg/dl than in those with values at or 
below 25 mg/dl (9.5% vs 5.4%, p<O.Ol). In contrast, the 
relation of Lp(a) to parental MI was not seen in black 
children. No associations were observed between 
parental MI and serum levels of any of the lipids or 
lipoprotein cholesterol classes in children of both 
races. Serum Lp(a) levels may prove valuable in the 
assessment of CAD risk early in life among white 
populations. These findings also emphasize the need to 
evaluate the atherogenic potential of Lp(a) in different 
racial groups. 
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APOLIPOPROTEINS A-I AND B-100 BETTER THAN STANDARD LIPID 
MEASUREMENTS IN DIFFERENTIATING BETWEEN PATIENTS WITH 
POSITIVE OR NEGATIVE CORONARY tiCIOGRAPHY? 
Howard Roaman, Jau-Wen Chu, Theresa 
Cruz, Henry Food Wospital, Detroit, Michigan. 
Low levels of apolipoprotein A-I (APO A-I) and high levela 
of apolipoproteina B-100 (APO B) have been associated with 
coronary artery disease (CAD). We studied 166 pta to 
determine whether Apo A-I and Apo B add discriminating 
value to standard lipid measurements in predicting the 
presence of CAD. CAD was defined as greater than 50X 
luminal narrowing on angioplaaty and was observed in 84pts 
(64 male CM), 20 female (I?)). Coronl‘ry disease was 
considered absent in 82 pta (38 M, 44 F) who had no 
luminal stenosis. 
Univariate values 
*Age 0.0004 TC/WL 0.0001 
*Male 0.0000 LDL/HDL 0.0001 
T. Chol 0.003 Apo A-I 0.89 
Trigly 0.63 Apo B 0.0002 
*LDL 0.0000 A-I/B ratio 0.0025 
HDL 0.0007 *Smoking 0.019 
*Also significant by multivariate analysis 
In the subset of 58 pts with CAD and normal cholesterol 
(~200 mg/dl) and LDL (cl30 mg/dl), Apo B and Apo A-I/APO B 
ratio did not improve discriminating power over LDL/HDL 
ratio. 
Conclusions: Measurement of apoproteina A-I and B does 
not improve the discriminating power of the commonly 
measured lipid parameters in predicting CAD in pta with 
elevated or normal cholesterol and LDL. These data do not 
support routine use of apoproteina in cardiac risk factor 
aaaeaament. 
3:IS 
Influence of the Selection of Angiographic Projections on 
the Outcome of Coronary Angiographic Follow-up Trials - 
Results from INTACT 
In a prospective angiographic follow-up trial (INTACT) 
including 348 patients with coronary artery disease stan- 
dardized coronary angiograms taken in multiple projec- 
tions were repeated after an interval of three years. The 
angiograms were analyzed with a computer-assisted contour 
detection system (CABS). A total of 1063 coronary steno- 
ses (ST), defined as diameter reduction 
pared between both angiograms. ST progr 
regression (RE) were defined as increas 
respectively, of percent diameter ST by 
presents the total number of ST with PRO and RE consi- 
dering either the mean change of percent diameter ste- 
nosis over all projections analyzed per patient (A), or 
Only the respective projections indicating the individual 
maximal PRO (6) or maximal RE (C). 
A 8 C 
ST with PRO 120(m) /I( 7x1* 
~p<0.001 
The marked differences between the results yielded with 
analysis patterns A, 8, and C demonstrate that selection 
of projections substantially influences the results. 
Thus, availability of a considerable number of different 
angiographic projections is mandatory in such trials. 
